| __timestamp | Arrowhead Pharmaceuticals, Inc. | BioCryst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 51796000 |
| Thursday, January 1, 2015 | 57410147 | 72758000 |
| Friday, January 1, 2016 | 41454452 | 61008000 |
| Sunday, January 1, 2017 | 31690298 | 66962000 |
| Monday, January 1, 2018 | 52968505 | 84888000 |
| Tuesday, January 1, 2019 | 81048686 | 107068000 |
| Wednesday, January 1, 2020 | 128874979 | 122964000 |
| Friday, January 1, 2021 | 206342000 | 208808000 |
| Saturday, January 1, 2022 | 297307000 | 253297000 |
| Sunday, January 1, 2023 | 353188000 | 216566000 |
| Monday, January 1, 2024 | 505870000 |
Igniting the spark of knowledge
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Arrowhead Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. have been at the forefront of this transformative journey. From 2014 to 2023, Arrowhead's R&D expenses surged by over 2,000%, reflecting its commitment to pioneering advancements. In contrast, BioCryst's R&D investments grew by approximately 318%, showcasing a steady dedication to innovation.
These trends underscore the dynamic nature of the biopharmaceutical industry, where strategic R&D investments are crucial for future breakthroughs.
Comparing Innovation Spending: AbbVie Inc. and Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Genmab A/S and BioCryst Pharmaceuticals, Inc.
Comparing Innovation Spending: Insmed Incorporated and Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Pharming Group N.V. and BioCryst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Alkermes plc vs Arrowhead Pharmaceuticals, Inc.
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: PTC Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Research and Development Investment: Ligand Pharmaceuticals Incorporated vs BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: Supernus Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Soleno Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Amphastar Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.